Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient‐reported outcomes from a Phase 3 study

Por Valenzuela, F., Paul, C., Mallbris, L., Tan, H., Papacharalambous, J., Valdez, H., Mamolo, C.
Publicado no J Eur Acad Dermatol Venereol (2016)

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

Por Beecker, J., Papp, K.A., Dutz, J., Vender, R.B., Gniadecki, R., Cooper, C., Gisondi, P., Gooderham, M., Hong, C.H., Kirchhof, M.G., Lynde, C.W., Maari, C., Poulin, Y., Puig, L.
Publicado no J Eur Acad Dermatol Venereol (2021)

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis

Por Warren, R.B., Barker, J.N.W., Van de Kerkhof, P., Reich, K., Mrowietz, U.
Publicado no J Eur Acad Dermatol Venereol (2019)

Recent outbreak of chilblain‐like lesions is not directly related to SARS‐CoV‐2 infection

Por Rouanet, J., Lang, E., Beltzung, F., Evrard, B., Henquell, C., Joulie, I., D'Incan, M.
Publicado no J Eur Acad Dermatol Venereol (2020)

Follow‐up of dermatological manifestations in non‐critical hospitalized patients with COVID‐19 pneumonia and their prognostic correlation with disease severity

Por García‐Irigoyen, A., Acatitla‐Acevedo, G.A., Barrera‐Godínez, A., Méndez‐Flores, S., Domínguez‐Cherit, J.
Publicado no J Eur Acad Dermatol Venereol (2021)

Non‐invasive imaging in dermatology and the unique potential of raster‐scan optoacoustic mesoscopy

Por Hindelang, B., Aguirre, J., Schwarz, M., Berezhnoi, A., Eyerich, K., Ntziachristos, V., Biedermann, T., Darsow, U.
Publicado no J Eur Acad Dermatol Venereol (2019)

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients

Por Roekevisch, E., Szegedi, K., Hack, D.P., Schram, M.E., Res, P.C.J.M., Bos, J.D., Leeflang, M.M.G., Luiten, R.M., Kezic, S., Spuls, P.I., Middelkamp‐Hup, M.A.
Publicado no J Eur Acad Dermatol Venereol (2020)

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatiti...

Por Wollenberg, A., Nakahara, T., Maari, C., Peris, K., Lio, P., Augustin, M., Silverberg, J.I., Rueda, M.J., DeLozier, A.M., Pierce, E., Yang, F.E., Sun, L., Ball, S., Tauber, M., Paul, C.
Publicado no J Eur Acad Dermatol Venereol (2021)

Stepwise approach of development of dermo‐cosmetic products in healthy and atopic dermatitis paediatric population: safety evaluation, clinical development and postmarket surveilla...

Por Ribet, V., Gurdak, M., Ferret, P.‐J., Brinio, E., Giordano Labadie, F., Rossi, A.B.
Publicado no J Eur Acad Dermatol Venereol (2019)

Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients

Por McCoy, J., Wambier, C.G., Herrera, S., Vaño‐Galván, S., Gioia, F., Comeche, B., Ron, R., Serrano‐Villar, S., Iwasiow, R.M., Tayeb, M.A., Cadegiani, F.A., Mesinkovska, N.A., Shapiro, J., Sinclair, R., Goren, A.
Publicado no J Eur Acad Dermatol Venereol (2020)

Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology

Por Jones, O.T., Jurascheck, L.C., Utukuri, M., Pannebakker, M.M., Emery, J., Walter, F.M.
Publicado no J Eur Acad Dermatol Venereol (2019)

Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: res...

Por Ortonne, J-P, Esposito, M, Chimenti, S, Kapińska-Mrowiecka, M, Grodzińska, A, Naldi, L, Frangione, V
Publicado no J Eur Acad Dermatol Venereol (2014)

Ultrasonographic Characteristics of Cutaneous Leishmaniasis

Por Saavedra, A. C., Valencia, B. M., Tueros, P., Wortsman, X., Llanos-Cuentas, A., Lavarello, R. J.
Publicado no J Eur Acad Dermatol Venereol (2020)

Facial swelling and foreign body granulomatous reaction to hyaluronic acid filler in the setting of tyrosine kinase inhibitor therapy

Por Hibler, B.P., Yan, B.Y., Marchetti, M.A., Momtahen, S., Busam, K.J., Rossi, A.M.
Publicado no J Eur Acad Dermatol Venereol (2018)

Did Whatsapp(®) reveal a new cutaneous COVID‐19 manifestation?

Por Duong, T.A., Velter, C., Rybojad, M., Comte, C., Bagot, M., Sulimovic, L., Bouaziz, J.D.
Publicado no J Eur Acad Dermatol Venereol (2020)

Nail changes as manifestation of systemic disease in COVID‐19 infection

Por Ocampo‐Garza, S.S., Ocampo‐Candiani, J., Camela, E., Vastarella, M., Fabbrocini, G., Scalvenzi, M., Villani, A.
Publicado no J Eur Acad Dermatol Venereol (2021)

Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID‐19 pandemic

Por García‐Gil, M.F., García García, M., Monte Serrano, J., Prieto‐Torres, L., Ara‐Martín, M.
Publicado no J Eur Acad Dermatol Venereol (2020)

Scabies outbreak during home confinement due to the SARS‐CoV‐2 pandemic

Por Martínez‐Pallás, I., Aldea‐Manrique, B., Ramírez‐Lluch, M., Manuel Vinuesa‐Hernando, J., Ara‐Martín, M.
Publicado no J Eur Acad Dermatol Venereol (2020)

Skin manifestations of the BNT162b2 mRNA COVID‐19 vaccine in healthcare workers. ‘COVID‐arm’: a clinical and histological characterization

Por Fernandez‐Nieto, D., Hammerle, J., Fernandez‐Escribano, M., Moreno‐del Real, C.M., Garcia‐Abellas, P., Carretero‐Barrio, I., Solano‐Solares, E., de‐la‐Hoz‐Caballer, B., Jimenez‐Cauhe, J., Ortega‐Quijano, D., Fernandez‐Guarino, M.
Publicado no J Eur Acad Dermatol Venereol (2021)

Secukinumab Treatment of Plaque Psoriasis Shows Early Improvement in DLQI Response — Results of a Phase 2 Regimen-Finding Trial

Por Augustin, M., Abeysinghe, S., Mallya, U., Qureshi, A., Roskell, N., McBride, D., Papavassillis, C., Gelfand, J.
Publicado no J Eur Acad Dermatol Venereol (2015)